Hansenula-derived Pegylated Interferon in Treatment of Patients With Chronic Hepatitis C

Clinical trial NCT01649245 · UNKNOWN

Trial details

NCT number: NCT01649245
Sponsor: MinaPharm Pharmaceuticals
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2012-08-01
Primary completion: 2014-08-01
Enrollment: 5000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.